Table 3.
Antimicrobial resistance profiles of A. baumannii.
| Antimicrobial | Resistance (n) % | Sign. | ||
|---|---|---|---|---|
| S | R | I | ||
| Tobramycin | (8) 34.8% | (15) 65.2% | 0 | 0.144 ns |
| Gentamycin | (5) 21.7% | (17) 73.9% | (1) 4.3% | <0.001 * |
| Amikacin | (11) 47.8% | (12) 52.2% | 0 | 0.835 ns |
| Aztreonam | (3) 13% | (20) 87% | 0 | <0.001 * |
| Norfloxacin | (7) 30.4% | (16) 69.6% | 0 | 0.061 ns |
| Levofloxacin | (6) 26.1% | (15) 65.2% | (2) 8.7% | 0.003 * |
| Ofloxacin | (8) 34.8% | (14) 60.9% | (1) 4.3% | 0.0004 * |
| Ciprofloxacin | (7) 30.4% | (16) 69.6% | 0 | 0.061 ns |
| Nalidixic acid | 0 | (23) 100% | 0 | <0.001 * |
| Piperacillin/tazobactam | (3) 13% | (19) 82.6% | (3) 13% | <0.001 * |
| Oxacillin | 0 | (23) 100% | 0 | <0.001 * |
| Amoxicillin/clavulanic acid | 0 | (23) 100% | 0 | <0.001 * |
| Ceftazidime | (2) 8.7% | (20) 87% | (1) 4.3% | <0.001 * |
| Cefotaxime | (1) 4.3% | (21) 91.3% | (1) 4.3% | <0.001 * |
| Cefepime | (9) 39.1% | (13) 56.5% | (1) 4.3% | 0.008 * |
| Meropenem | (8) 34.8% | (12) 52.2% | (3) 13% | 0.070 ns |
| Imipenem | (10) 39.1% | (11) 47.8% | (2) 8.7% | <0.001 * |
| Ertapenem | (3) 13% | (20) 87% | 0 | <0.001 * |
| Doripenem | (5) 21.7% | (17) 73.9% | (1) 4.3% | <0.001 * |
| Colistin | (17) 73.9% | (4) 17.4% | (2) 8.7% | <0.001 * |
| Polymyxin B | (19) 82.6% | (4) 17.4% | 0 | 0.002 * |
* significant at p < 0.05; ns, non-significant at p > 0.05.